Cargando…

Intercellular Communication between Hepatic Cells in Liver Diseases

Liver diseases are perpetuated by the orchestration of hepatocytes and other hepatic non-parenchymal cells. These cells communicate and regulate with each other by secreting mediators such as peptides, hormones, and cytokines. Extracellular vesicles (EVs), small particles secreted from cells, contai...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sato, Keisaku, Kennedy, Lindsey, Liangpunsakul, Suthat, Kusumanchi, Praveen, Yang, Zhihong, Meng, Fanyin, Glaser, Shannon, Francis, Heather, Alpini, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540342/ https://www.ncbi.nlm.nih.gov/pubmed/31052525 http://dx.doi.org/10.3390/ijms20092180

Ejemplares similares

Pro‐inflammatory signalling and gut‐liver axis in non‐alcoholic and alcoholic steatohepatitis: Differences and similarities along the path
por: Glaser, Trenton, et al.
Publicado: (2020)

Dual Role of Bile Acids on the Biliary Epithelium: Friend or Foe?
por: Baiocchi, Leonardo, et al.
Publicado: (2019)

The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles
por: Sato, Keisaku, et al.
Publicado: (2017)

Author Correction: The role of the secretin/secretin receptor axis in inflammatory cholangiocyte communication via extracellular vesicles
por: Sato, Keisaku, et al.
Publicado: (2018)

Pathophysiological Roles of Ductular Reaction in Liver Inflammation and Hepatic Fibrogenesis
por: Sato, Keisaku, et al.
Publicado: (2022)

Knockdown of vimentin reduces mesenchymal phenotype of cholangiocytes in the Mdr2(−/−) mouse model of primary sclerosing cholangitis (PSC)
por: Zhou, Tianhao, et al.
Publicado: (2019)

Critical Role of microRNA-21 in the Pathogenesis of Liver Diseases
por: Zhang, Ting, et al.
Publicado: (2020)

Concise Review: Functional Roles and Therapeutic Potentials of Long Non-coding RNAs in Cholangiopathies
por: Sato, Keisaku, et al.
Publicado: (2020)

Neuroendocrine Changes in Cholangiocarcinoma Growth
por: Sato, Keisaku, et al.
Publicado: (2020)

Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease
por: Han, Sen, et al.
Publicado: (2020)

Current Advances in Basic and Translational Research of Cholangiocarcinoma
por: Sato, Keisaku, et al.
Publicado: (2021)

Alcohol Metabolizing Enzymes, Microsomal Ethanol Oxidizing System, Cytochrome P450 2E1, Catalase, and Aldehyde Dehydrogenase in Alcohol-Associated Liver Disease
por: Jiang, Yanchao, et al.
Publicado: (2020)

Biliary Epithelial Senescence in Liver Disease: There Will Be SASP
por: Meadows, Vik, et al.
Publicado: (2021)

Feedback Signaling between Cholangiopathies, Ductular Reaction, and Non-Alcoholic Fatty Liver Disease
por: Zhou, Tianhao, et al.
Publicado: (2021)

Impact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

The functional role of microRNAs in alcoholic liver injury
por: McDaniel, Kelly, et al.
Publicado: (2014)

Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice
por: Kennedy, Lindsey, et al.
Publicado: (2016)

Cyclic AMP Signaling in Biliary Proliferation: A Possible Target for Cholangiocarcinoma Treatment?
por: Baiocchi, Leonardo, et al.
Publicado: (2021)

Serum Metabolomic Profiling Identifies Key Metabolic Signatures Associated With Pathogenesis of Alcoholic Liver Disease in Humans
por: Yang, Zhihong, et al.
Publicado: (2019)

Macrophage-Specific SCAP Promotes Liver and Adipose Tissue Damage in a Lean NAFLD Model: Lean, Mean, Proinflammatory Machine
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Role of stem cells during diabetic liver injury
por: Wan, Ying, et al.
Publicado: (2015)

The Effects of Taurocholic Acid on Biliary Damage and Liver Fibrosis Are Mediated by Calcitonin-Gene-Related Peptide Signaling
por: Mancinelli, Romina, et al.
Publicado: (2022)

Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes
por: Wan, Ying, et al.
Publicado: (2019)

Bile Acid Receptor Therapeutics Effects on Chronic Liver Diseases
por: Meadows, Vik, et al.
Publicado: (2020)

Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
por: Lewis, Phillip L., et al.
Publicado: (2018)

Author Correction: Complex bile duct network formation within liver decellularized extracellular matrix hydrogels
por: Lewis, Phillip L., et al.
Publicado: (2023)

Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development
por: Ceci, Ludovica, et al.
Publicado: (2022)

The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease
por: Yang, Zhihong, et al.
Publicado: (2021)

Activin B promotes the initiation and progression of liver fibrosis
por: Wang, Yan, et al.
Publicado: (2022)

The emerging role of cellular senescence in renal diseases
por: Zhou, Bingru, et al.
Publicado: (2020)

Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2(−/−) mice by diminishing senescence of cholangiocytes
por: Zhou, Tianhao, et al.
Publicado: (2018)

Comprehensive Review of Molecular Mechanisms during Cholestatic Liver Injury and Cholangiocarcinoma
por: Virani, Shohaib, et al.
Publicado: (2018)

Biliary damage and liver fibrosis are ameliorated in a novel mouse model lacking l-histidine decarboxylase/histamine signaling
por: Kennedy, Lindsey, et al.
Publicado: (2020)

Adipose Tissue Inflammation and Systemic Insulin Resistance in Mice with Diet-induced Obesity Is Possibly Associated with Disruption of PFKFB3 in Hematopoietic Cells
por: Zhu, Bilian, et al.
Publicado: (2021)

Distinct histopathological phenotypes of severe alcoholic hepatitis suggest different mechanisms driving liver injury and failure
por: Ma, Jing, et al.
Publicado: (2022)

Role of Non-Coding RNAs in the Progression of Liver Cancer: Evidence from Experimental Models
por: O’Brien, April, et al.
Publicado: (2019)

Ursodeoxycholate inhibits mast cell activation and reverses biliary injury and fibrosis in Mdr2(−/−) mice and human primary sclerosing cholangitis
por: Meng, Fanyin, et al.
Publicado: (2018)

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis
por: Kennedy, Lindsey, et al.
Publicado: (2022)

Reporting the cases of alcohol-associated hepatitis using the National Inpatient Sample data
por: Marlowe, Natalie, et al.
Publicado: (2023)

Transcriptomic Analysis Reveals the Messenger RNAs Responsible for the Progression of Alcoholic Cirrhosis
por: Yang, Zhihong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iio7jjtdcgvp6a8dmveek19srt